CRP and COVID-19: Notably, NAC may exhibit heightened efficacy as a prophylactic or adjunctive therapy in cases of stable nonsevere COVID‐19, with a particularly positive role in augmenting oxygen saturation levels and expediting the reduction of CRP and associated inflammation.